Users Coming Off Weight-Loss Jabs Gain Back Weight Four Times Faster Than People Using Diet and Exercise

A recent study reveals that people who discontinue popular GLP-1 drugs like Mounjaro or Wegovy can put back on reduced body mass far faster than those who stop conventional lifestyle regimens.

Research printed in a prominent medical journal points out that while obese individuals often shed substantial amounts of their total mass while using the jabs, the weight returns at an average rate of nearly a kilo each month after stopping.

"People purchasing such medications need to be aware of the potential of fast rebound weight gain when the medication is stopped," stated researcher Dr. Susan Jebb.

Such speed of recovery means a return to original mass within about a year and a half.

Analyzing Approaches

The research, which examined dozens of trials involving thousands of patients, compared the effects of the injectable medications with older methods.

Researchers emphasize that people who lose weight through dieting typically see a less rapid creep back—perhaps 100 grams monthly—post-intervention.

Explaining the Fast Rebound

Experts believe the way of the jabs explains the amplified weight return.

These medications copy a natural hormone called glucagon-like peptide-1, which controls appetite.

"Artificially providing the hormone levels far above than the body's typical production could lead to the system to produce less of its own natural GLP-1, and may also diminish sensitivity to its effects," noted Dr. Adam Collins, a dietetics expert.

"Withdrawal of this medication results in hunger is uncontrolled, making excessive eating a significant risk."

An Ongoing Issue?

Medical guidelines suggest the jabs for people with weight-linked health risks, alongside recommended lifestyle changes.

Professionals argue that, considering the significant potential of weight regain, the treatment is often life-long.

This perspective is reinforced by pharmaceutical companies, who state that the results "highlight the persistent nature of obesity," akin to managing conditions like high blood pressure.

User Accounts

People who have discontinued the jabs describe a sudden resurgence of appetite.

"It was like a switch that goes on and I was suddenly extremely hungry," recalled one woman.

This difficulty is compounded if users have not established lasting lifestyle or habit modifications during therapy.

Widespread Use

Figures show that millions of adults in the UK have tried these injections in the last 12 months, with demand continuing to grow.

• Adoption is higher among females compared to males.
• The middle-aged demographic shows the greatest usage rates.
• A large proportion obtain the drugs through private prescriptions rather than the NHS.

Ultimately, clinicians stress that while the jabs are potent tools for shedding pounds, they are not a permanent solution and long-term success relies on combined behavioural management.